SCHEMBL1676007

SCHEMBL1676007

COc1ccccc1-c1cc(=O)c2c(OC)cccc2o1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.74
HPGD P15428 6/20 0.74
CYP3A4 P08684 5/20 0.74
KDM4E B2RXH2 5/20 0.74
MAPT P10636 4/20 0.74
AR P10275 3/20 0.74
HSD17B10 Q99714 3/20 0.74
TP53 P04637 3/20 0.74
AHR P35869 1/20 0.69
NPC1 O15118 3/20 0.66
RAB9A P51151 3/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
POLH Q9Y253 1/20 0.66
LMNA P02545 1/20 0.66
TDP1 Q9NUW8 1/20 0.66
CYP2C19 P33261 3/20 0.64
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
CYP2D6 P10635 2/20 0.64
CYP2C9 P11712 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26605016 0.90 POLH (0.73) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL9137850 0.89 HPGD (0.75) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL4650059 0.89 ATM (0.69) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL10432585 0.89 ALDH1A1 (0.63) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL26604983 0.89 AR (0.67) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL15630238 0.86 HPGD (0.61) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL15619737 0.86 BCHE (0.66) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL9141356 0.85 ALDH1A1 (0.62) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL253522 0.85 HPGD (0.78) ALDH1A1HPGDCYP3A4KDM4EMAPT
SCHEMBL1629391 0.85 ALDH1A1 (1.00) ALDH1A1HPGDCYP3A4KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 EP disclosed
US-20150291547-A1 SMALL MOLECULES FOR EXTENDING THE WELL BEING OF CELLS AND METHODS OF USE THEREOF NANYANG POLYTECHNIC (SG) 2015-10-15 US disclosed
US-20150291547-A1 SMALL MOLECULES FOR EXTENDING THE WELL BEING OF CELLS AND METHODS OF USE THEREOF NANYANG POLYTECHNIC (SG) 2015-10-15 US disclosed
US-20140186277-A1 Methods and Compositions for Reducing Skin Damage SHISEIDO CO., LTD. (JP) 2014-07-03 US disclosed
US-20140135433-A1 TIRE WITH RUBBER CONTAINING FLAVONE THE GOODYEAR TIRE & RUBBER COMPANY (US) 2014-05-15 US disclosed
EP-2730431-A1 Rubber composition and tire with rubber containing flavone The Goodyear Tire & Rubber Company (US) 2014-05-14 EP disclosed
US-20110091387-A1 METHODS AND COMPOSITIONS FOR REDUCING SKIN DAMAGE THE GENERAL HOSPITAL CORPORATION (US) 2011-04-21 US disclosed
US-20100305068-A1 COMPOUNDS AND METHODS FOR MODULATING PROTEIN TRAFFICKING FOLDRX PHARMACEUTICALS, INC. (US) 2010-12-02 US disclosed
WO-2006030322-A2 USE OF FLA VONE/FLA VANONE DERIVATIVES FN THE TREATMENT OR PREVENTION OF RESPIRATORY CONDITIONS UNIVERSITY OF MANITOBA (CA) 2006-03-23 WO disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 EP disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US disclosed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305068-A1 COMPOUNDS AND METHODS FOR MODULATING PROTEIN TRAFFICKING GOLT1B, NPC1L1, NPC1 ALDH1A1 3582/4885HPGD 4457/4885CYP3A4 4800/4885
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP ALDH1A1 2440/4885HPGD 558/4885CYP3A4 3010/4885
US-20150291547-A1 SMALL MOLECULES FOR EXTENDING THE WELL BEING OF CELLS AND METHODS OF USE THEREOF TERT, POT1, TERF2 ALDH1A1 2026/4885HPGD 1283/4885CYP3A4 4867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.